BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16450143)

  • 1. Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice.
    Abdul-Hai A; Ben-Yehuda A; Galsky H; Slavin S; Or R
    Cancer Immunol Immunother; 2006 Nov; 55(11):1330-6. PubMed ID: 16450143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of interleukin-2 in immunologic reconstitution following bone marrow transplantation in mice.
    Abdul-Hai A; Lorberboum-Gliski H; Mechushtan A; Weiss L; Slavin S; Or R
    J Interferon Cytokine Res; 1995 Jan; 15(1):95-101. PubMed ID: 7648439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.
    Alpdogan O; Schmaltz C; Muriglan SJ; Kappel BJ; Perales MA; Rotolo JA; Halm JA; Rich BE; van den Brink MR
    Blood; 2001 Oct; 98(7):2256-65. PubMed ID: 11568014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7.
    Bolotin E; Smogorzewska M; Smith S; Widmer M; Weinberg K
    Blood; 1996 Sep; 88(5):1887-94. PubMed ID: 8781449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapy.
    Weiss L; Reich S; Slavin S
    Cancer Invest; 1992; 10(1):19-26. PubMed ID: 1735011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.
    Hosaka N; Cui W; Zhang Y; Takaki T; Inaba M; Ikehara S
    Cancer Immunol Immunother; 2010 Jul; 59(7):1121-30. PubMed ID: 20229083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitation of hematopoietic recovery by bone grafts with intra-bone marrow-bone marrow transplantation.
    Song C; Hisha H; Wang X; Li Q; Li M; Cui W; Guo K; Okazaki S; Mizokami T; Kato J; Cui Y; Feng W; Zhang Y; Shi M; Inaba M; Fan H; Ikehara S
    Immunobiology; 2008; 213(6):455-68. PubMed ID: 18514748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
    Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
    Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation.
    Kelly RM; Goren EM; Taylor PA; Mueller SN; Stefanski HE; Osborn MJ; Scott HS; Komarova EA; Gudkov AV; Holländer GA; Blazar BR
    Blood; 2010 Feb; 115(5):1088-97. PubMed ID: 19965631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engraftment of splenic tissue as a method to investigate repopulation by hematopoietic cells from host and donor marrow.
    Shatry AM; Levy RB
    Stem Cells Dev; 2004 Aug; 13(4):390-9. PubMed ID: 15345133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intrabone marrow-bone marrow transplantation plus adult thymus transplantation on survival of mice bearing leukemia.
    Zhang Y; Hosaka N; Cui Y; Shi M; Li M; Li Q; Ikehara S
    Stem Cells Dev; 2012 Jun; 21(9):1441-8. PubMed ID: 21861761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.
    Tormo A; Khodayarian F; Cui Y; Al-Chami E; Kanjarawi R; Noé B; Wang H; Rafei M
    J Hematol Oncol; 2017 Jun; 10(1):120. PubMed ID: 28615039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation.
    Chung B; Barbara-Burnham L; Barsky L; Weinberg K
    Blood; 2001 Sep; 98(5):1601-6. PubMed ID: 11520813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines.
    Slavin S; Ackerstein A; Weiss L; Nagler A; Or R; Naparstek E
    Cancer Invest; 1992; 10(3):221-7. PubMed ID: 1581831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
    Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.